Thrombocytopenias and Platelet Function Disorders
The SWG was established at the 2003 EHA Congress, which was held in Lyon, France. The group's original focus was thrombocytopenias, but it subsequently expanded its field of interest with the inclusion of platelet function disorders.
Purposes of the group
- To promote education and instruction in platelet disorders by scientific conference, webinars, and the annual meeting at the EHA Congress.
- To develop guidelines for diagnosis and/or treatment of thrombocytopenias and platelet function disorders.
- To promote clinical and laboratory studies on thrombocytopenias and platelet function disorders. The studies are conducted under the auspices of the EHA-SWG, but are open to collaboration with all interested researchers.
- To stimulate whenever possible joint initiatives with other EHA-SWGs and other scientific societies interested in platelet diseases.
Subcommittees and related coordinators
- Subcommittee for Adult ITP—Francesco Rodeghiero (Italy).
- Subcommittee for Childhood ITP—Thomas Kühne (Switzerland).
- Subcommittee for Inherited Thrombocytopenias—Patrizia Noris (Italy).
- Subcommittee for Inherited and Acquired Platelet Function Disorders—Ana C. Glembotsky (Argentina)
- Subcommittee for Drug-induced Thrombocytopenias—Andreas Greinacher (Germany), to be replaced.
- Subcommittee for Biology of Megakaryocytes and Thrombopoiesis—Hana Raslova (France).
- Subcommittee for Thrombotic Microangiopathies—Marie Scully (United Kingdom).
Recent webinar
In October 2023, we held a free webinar in collaboration with the Specialized Working Group on Bleeding and Thrombosis. The webinar was entitled: ‘The interaction of von Willebrand factor with platelet glycoprotein Ib: pathological implications and clinical manifestations.’
To find out more about the event and watch the full video, visit the webinar's page.
Become a registered member of this Specialized Working Group: Apply here
Back